Word

CELEGAGE

Status

Pending

Status Code

661

Status Date

Wednesday, May 29, 2024

Serial Number

79386468

Mark Type

4

Filing Date

Tuesday, October 17, 2023

Trademark Owner History

Rejuvenate Biomed NV

Classifications

9 Laboratory apparatus and instruments for inputting, extracting, transmitting, processing and storing data, in particular scientific and medical data, namely laboratory robots, data processors, electronic data loggers; scientific research and laboratory apparatus, namely, bio-chips for research or scientific purposes, pharmaceutical and scientific research equipment for use in mass spectrometers, electrodes for laboratory research; educational apparatus and simulators, namely, downloadable educational software featuring instruction in electronic clinicians training simulators; incubators for laboratory use; bioreactors for laboratory use; models for scientific experiments in laboratories, namely, downloadable computer simulation software for modeling the impact of drug combinations on health span markers; DNA chips; downloadable artificial intelligence software for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; downloadable artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; downloadable artificial intelligence software for data analysis; downloadable software using artificial intelligence for machine learning for healthcare; downloadable health monitoring software; downloadable software relating to the medical field for controlling and managing patient medical information; downloadable software relating to the pharmaceutical field for drug discovery and development; downloadable bioinformatics software for drug discovery and development, for controlling and managing patient medical information; electronic databases, namely, downloadable databases, electronic database recorded on computer media, for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data

44 Pharmaceutical services, namely, pharmaceutical compounding, pharmaceutical advice; pharmaceutical consultation; pharmaceutical advisory services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services; medical consultancy services; medical advisory services; medical evaluation services, namely, medical testing for fitness evaluation, medical evaluation of cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and conditions, conducting medical physical evaluations; medical diagnostic services; medical examination services; services for the provision of medical care information, namely, providing medical care information, providing medical care information via a website; medical services for the diagnosis of conditions of the human body; medical services for the treatment of conditions of the human body; performing diagnosis of diseases; medical care and analysis services relating to patient treatment; medical screening; drug screening for medical purposes; medical and health services relating to dna, genetics and genetic testing, namely, medical services, medical consultations, health care; genetic testing for medical purposes; medical tests, namely, medical testing services; provision of medical information in the field of prevention, screening, diagnosis and treatment of patients

42 Pharmaceutical research services; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research of pharmaceuticals; testing of pharmaceuticals; research relating to pharmaceuticals; pharmaceutical products development; development of gene-based medicines; drug discovery services; conducting clinical trials for others for pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment, namely, conducting scientific feasibility studies; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals, pharmaceutical research and development; toxicity testing for scientific research purposes; toxicity analysis for scientific research purposes; information technology services for the pharmaceutical and healthcare industries, namely, information technology consultancy relating to installation, maintenance and repair of computer software; conducting early evaluations in the field of new pharmaceuticals, namely, testing of pharmaceuticals; providing information about pharmaceutical research, namely, the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals; chemical research and analysis services; medical and pharmacological research services; scientific services and research relating thereto, namely, scientific research, scientific laboratory services, scientific research consulting; scientific research for medical purposes; scientific research for medical purposes in the area of diseases; medical and scientific research, namely, conducting clinical trials for others; genetic research, namely, providing scientific research information in the field of genetics, providing medical research information in the field of genetics; genetic mapping for scientific purposes; dna screening for scientific research purposes; providing scientific information in the field of medical disorders and their treatment; Providing temporary use of non-downloadable artificial intelligence computer programs on data networks for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; platforms for artificial intelligence as software as a service (SaaS), namely, platform as a service (PAAS) featuring computer software platforms using artificial intelligence for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) services featuring computer software platforms for artificial intelligence for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) services featuring software for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SaaS) services featuring artificial intelligence software for data analysis; software as a service (SaaS) services featuring software using artificial intelligence for machine learning for healthcare; software as a service (SaaS) services featuring health monitoring software; software as a service (SaaS) services featuring software relating to the medical field for controlling and managing patient medical information; software as a service (SaaS) services featuring bioinformatics software for drug discovery and development, for controlling and managing patient medical information; providing temporary use of non- downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; computer programming in the medical field; scientific computer programming services; artificial intelligence technology consultancy; research in the field of artificial intelligence

Trademark Events

Mar 28, 2024

Non-Final Action Written

Dec 28, 2023

Sn Assigned For Sect 66a Appl From Ib

Dec 29, 2023

New Application Office Supplied Data Entered

Jan 2, 2024

Application Filing Receipt Mailed

Mar 27, 2024

Assigned To Examiner

Apr 16, 2024

Refusal Processed By Mpu

Apr 17, 2024

Non-Final Action Mailed - Refusal Sent To Ib

May 9, 2024

Refusal Processed By Ib

Mar 29, 2024

Non-Final Action (Ib Refusal) Prepared For Review

May 29, 2024

Correspondence Received In Law Office

May 29, 2024

Teas/Email Correspondence Entered

May 29, 2024

Teas Response To Office Action Received